Herschorn, S.; Nazir, J.; Ramos, B.; Hakimi, Z. Supplementary Data: Cost-Effectiveness of Mirabegron Compared to Tolterodine ER 4 Mg for Overactive Bladder in Canada. CUAJ 2017, 11, E129-33.